Navigation Links
InfoLogix, Inc. to Present at the Growth & Investor Conference in Fort Lauderdale, FL
Date:2/20/2008

HATBORO, Pa., Feb. 20 /PRNewswire-FirstCall/ -- InfoLogix, Inc. (Nasdaq: IFLG), a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, announced today that David Gulian, President and CEO, will present at the Growth & Value Investor Conference to be held at the Westin Fort Lauderdale in Florida on February 27-28, 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071101/NETH165LOGO )

Mr. Gulian is scheduled to present on Thursday, February 28th followed by a question and answer session. The Growth & Value Investor Conference will be held at the Westin Fort Lauderdale, located at 400 Corporate Drive, Fort Lauderdale, FL. The slide presentation discussed at the conference will be available on InfoLogix's website located at http://www.infologix.com. Electronic versions of the presentation can also be received via email, fax or postal service by contacting InfoLogix's Investor Relations department at the address provided at the end of this release.

InfoLogix's enterprise mobility solutions have been selected by more than 1,400 hospitals and 800 commercial organizations, including 47 of the Fortune 500, to improve productivity, efficiency and revenues. Most recently, InfoLogix has been spotlighted in a FOX Business News feature on medication management and attracted former executives from SAP Americas and GE Healthcare to its team.

About InfoLogix, Inc.

InfoLogix is a leading provider of technology and RFID based intelligence solutions that enable the mobile enterprise. InfoLogix uses the industry's most advanced technologies to increase the efficiency, accuracy, and transparency of complex business and clinical processes for the healthcare industry and the commercial marketplace. With 19 issued patents, InfoLogix provides mobile managed solutions, on-demand software applications, mobile infrastructure products, and strategic consulting services to over 2,000 clients in North America including Kraft Foods, Merck and Company, General Electric, Kaiser Permanente, Adventist Health, Swedish Medical Center, and Stanford School of Medicine. Founded in 2001 and headquartered in suburban Philadelphia, PA, InfoLogix has been named the sixth fastest growing new business in the United States for the last three years by Entrepreneur Magazine. InfoLogix is a publicly-traded company (Nasdaq: IFLG). For more information, visit http://www.infologix.com.

About the Growth & Value Investor Conference

The Growth & Value Investor Conference has carefully designated upwards of 30 outstanding publicly traded companies (NYSE, NASDAQ, AMEX, Canadian listed companies and more) and offers you a live, inside look into the core of their strategies, strength of management and the potential for profit. Each corporate presentation is planned to be followed by a question and answer session and one-on-one meeting opportunities are available. There is nothing to buy at the Growth & Value Investor Conference. All are welcome. Attendance is free.

The Growth & Value Investor Conference, "Spring Break for Wall Street," will be held on Wednesday and Thursday, February 27 & 28, 2008. The Complimentary Cocktail Reception will be held from 4:00 PM - 5:00 PM and the Corporate Presentations will follow from 5:00 PM - 9:00 PM. The Growth & Value Investor Conference is presented by LDV Capital Management, a Registered Investment Advisory Firm Licensed with the State of Florida.


'/>"/>
SOURCE InfoLogix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
2. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
3. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
4. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
5. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
6. AtriCure to Present at Roth Capital Partners 2007 New York Conference
7. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
8. MDS to Present at Thomas Weisel Partners Healthcare Conference
9. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
10. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
11. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... Thomas ... perseverance and disciplined exercise regime, the author was able to successfully recover. In “ ... all relevant information for various sources on the principals of massage, anatomy , ...
(Date:2/22/2017)... East Setauket, New York (PRWEB) , ... February ... ... the main floor entrance and lobby of a new healthcare contact center in ... gleaming results. , One of the nation’s largest healthcare systems recently invested $51 ...
(Date:2/22/2017)... ... February 22, 2017 , ... Gevir, a New Zealand-based ... velvet, announced its products are coming soon to Amazon.com, the world’s largest online retailer. ... as a means to develop an effective natural treatment for Shelley’s Multiple Sclerosis, which ...
(Date:2/22/2017)... ... 22, 2017 , ... The Waismann Method® is providing a faster, ... recently fallen victim to America’s opioid epidemic. Now, opiate dependent individuals can be treated ... free from the shame, stigma, and harmful labeling believed to prevent many ...
(Date:2/22/2017)... ... February 22, 2017 , ... The National Academy of Certified ... the April 2017 testing period. NACCM, a nonprofit organization, has provided the premier ... exam is periodically re-calibrated to ensure that newly certified professionals are prepared to ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... February 23, 2017 ML Capital Group, Inc. ... Colorado Highlife Tours , a Colorado ... partnership with Puration, Inc. (USOTC: PURA) to enter Colorado,s ... product. The Colorado Highlife Tours acquisition announced today is intended to ... ...
(Date:2/23/2017)... 23, 2017 MabVax Therapeutics Holdings, ... development company, announces that it has received notice ... authorizing the initiation a Phase I clinical trial ... cancer. MVT-1075 ( 177 Lu-CHX-A?-DTPA-HuMab5B1) is the Company,s ... to initiate the phase I clinical trial in ...
(Date:2/23/2017)... Wash. and VANCOUVER, British Columbia ... (NASDAQ: OGXI ) today announced its year ... In January 2017, OncoGenex, and Achieve Life ... that they have entered into a definitive merger agreement ... transaction. Upon completion of the proposed merger, Achieve,s stockholders ...
Breaking Medicine Technology: